COR vs. CAH, MCK, EW, IQV, TAK, DXCM, MRNA, IDXX, CNC, and GEHC
Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include Cardinal Health (CAH), McKesson (MCK), Edwards Lifesciences (EW), IQVIA (IQV), Takeda Pharmaceutical (TAK), DexCom (DXCM), Moderna (MRNA), IDEXX Laboratories (IDXX), Centene (CNC), and GE HealthCare Technologies (GEHC). These companies are all part of the "medical" sector.
Cardinal Health (NYSE:CAH) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment.
Cardinal Health currently has a consensus price target of $103.07, indicating a potential downside of 0.13%. Cencora has a consensus price target of $218.22, indicating a potential downside of 9.41%. Given Cencora's higher possible upside, equities research analysts plainly believe Cardinal Health is more favorable than Cencora.
Cardinal Health received 164 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 71.68% of users gave Cardinal Health an outperform vote while only 65.03% of users gave Cencora an outperform vote.
87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.2% of Cardinal Health shares are owned by insiders. Comparatively, 15.8% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Cencora has higher revenue and earnings than Cardinal Health. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.
Cardinal Health has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500.
In the previous week, Cardinal Health had 42 more articles in the media than Cencora. MarketBeat recorded 46 mentions for Cardinal Health and 4 mentions for Cencora. Cardinal Health's average media sentiment score of 0.49 beat Cencora's score of 0.08 indicating that Cencora is being referred to more favorably in the news media.
Cardinal Health pays an annual dividend of $2.00 per share and has a dividend yield of 1.9%. Cencora pays an annual dividend of $2.04 per share and has a dividend yield of 0.8%. Cardinal Health pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cencora pays out 22.2% of its earnings in the form of a dividend. Cardinal Health has raised its dividend for 27 consecutive years and Cencora has raised its dividend for 1 consecutive years. Cardinal Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Cencora has a net margin of 0.69% compared to Cencora's net margin of 0.30%. Cardinal Health's return on equity of 323.23% beat Cencora's return on equity.
Summary
Cencora beats Cardinal Health on 12 of the 21 factors compared between the two stocks.
Get Cencora News Delivered to You Automatically
Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
